Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB01889ExperimentalSmall molecule
16,17-Androstene-3-Ol: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Nuclear receptor subfamily 1 group I member 3
- Formula / weight
- C19H30O · 274.4409 g/mol (avg)
Resolves to
Structure
InChIKey
KRVXMNNRSSQZJP-PHFHYRSDSA-NSMILES[H][C@@]12CC=C[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@]([H])(O)CC[C@]12CTargets
What you can answer from here — as of September 23, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with 16,17-Androstene-3-Ol, and which of those have an active Phase 3 trial?